Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy

This study has been completed.
Sponsor:
Collaborators:
Tufts Medical Center
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Aadia Rana, The Miriam Hospital
ClinicalTrials.gov Identifier:
NCT00887653
First received: April 23, 2009
Last updated: April 16, 2014
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)